Imax CORP

Market Movers (8-K)

See all →
NYSE
IMAX Corporation announced a third amendment to its Chief Legal Officer's employment agreement, extending the term to December 31, 2029, with clarified terms for unvested equity awards.
NYSE
IMAX Corporation announced robust second quarter 2026 financial and operating results, driven by strong box office performance and network expansion, exceeding analyst consensus.
Better than expected
NYSE
IMAX Corporation's 2026 Annual General Meeting saw shareholders re-elect all ten directors, approve PricewaterhouseCoopers LLP as auditors, and pass an advisory vote on executive compensation.
NYSE
IMAX Corporation has appointed Robert D. Lister as interim principal executive officer while CEO Richard Gelfond is on temporary medical leave.
NYSE
IMAX Corporation announced CEO Richard Gelfond is on a temporary medical leave of absence for pneumonia treatment, with senior executives and the Board Chairman managing operations.
NYSE
IMAX Corporation reported exceptional financial results for full-year 2025, exceeding key metrics and providing strong 2026 guidance driven by a robust content slate and network expansion.
Better than expected
Capital raise

Quarterly Earnings (10-Q)

See all →
NYSE
IMAX Corporation announced its second quarter 2026 financial results, showcasing a significant increase in revenue and gross margin, primarily fueled by a rise in IMAX system installations and robust global box office performance.
NYSE
IMAX reports Q1 2026 revenue of $81.4 million, impacted by a challenging year-over-year comparison in the Greater China market.
Worse than expected
NYSE
IMAX Corporation reports significant revenue and profit increases for Q3 and year-to-date 2025, driven by record global box office performance and strategic expansion.
Better than expected
NYSE
IMAX Corporation announced significant financial improvements for the second quarter and first half of 2025, with revenues and net income rising sharply due to robust global box office performance and strategic cost reductions.
Better than expected
NYSE
IMAX Corporation reports a 10% increase in revenue and a 13% increase in gross margin for Q1 2025, driven by international box office success and increased system installations.
Better than expected
NYSE
IMAX Corporation's Q3 results show a decrease in revenue due to lower box office performance, but an increase in net income due to cost-cutting measures.
Worse than expected

Annual Reports (10-K)

NYSE
IMAX Corporation reported a record global box office of $1.28 billion in 2025, driven by a diverse content slate and significant international network expansion.
Better than expected
Delay expected
Capital raise
NYSE
IMAX Corporation's 2024 results reveal a mixed performance, with revenue decline offset by strategic growth in system installations and operational efficiencies, while facing challenges in the Chinese market.
Delay expected
Worse than expected
NYSE
IMAX Corporation files its annual 10-K report, highlighting a strong financial year and amending an executive employment agreement.
Better than expected

Insider Trading (Form 4)

See all →
NYSE
Robert D Lister, Chief Legal Officer Sr Exec VP of Imax Corp, sold 22,500 shares of common stock on September 10, 2026 for $51.58 per share.
NYSE
Mark Welton, President IMAX Global Theatres of Imax Corp, sold 30,000 shares of common stock on August 25, 2026 for $54.47 per share.
NYSE
Kenneth Ian Weissman, Deputy GC, Corp. Sec. & CCO of Imax Corp, sold 8,000 shares of common stock on August 25, 2026 for $54.54 per share.
NYSE
Calamera Pablo, CTO & EVP of Imax Corp, sold 15,000 shares of common stock on August 20, 2026 for $52.41 per share.
NYSE
Richard L Gelfond, Chief Executive Officer and a Director of Imax Corp, sold 456,757 shares of common stock on August 18, 2026.
NYSE
IMAX Corp director Darren Throop reported transactions involving common shares and restricted share units on June 11, 2026.

Proxy Statements (Def-14A)

NYSE
IMAX Corporation reports record 2025 financial performance and outlines proposals for its 2026 Annual General Meeting, including executive compensation and director elections.
Better than expected
NYSE
IMAX anticipates its best year ever at the global box office in 2025, driven by a robust film slate and continued network expansion.
Better than expected
NYSE
IMAX Corporation's 2023 was a strong year, with revenue and global box office numbers reaching near record levels, and shareholders are invited to attend the 2024 Annual General Meeting to vote on key proposals.
Better than expected
Delay expected

Schedule 13D - Activist Investments

NYSE
The Douglas family and associated trusts have collectively sold 568,000 IMAX Corporation common shares in a block transaction at $37.82 per share.
Worse than expected
NYSE
An amendment to Schedule 13D details the beneficial ownership of IMAX Corporation common shares by the Douglas family and related trusts, with Kevin Douglas holding 16.5% and Michelle Douglas holding 12.1%.

Schedule 13G - Passive Investments

See all →
NYSE
Nomura Asset Management International Inc. and Nomura Investment Management Business Trust have jointly filed a Schedule 13G, reporting a 5.4% beneficial ownership of IMAX Corp. common shares as of June 30, 2026.
NYSE
Orbis Investment Management Limited and Allan Gray Australia Pty Ltd have collectively increased their beneficial ownership in IMAX Corp to 9.4%, signaling strong institutional conviction.
NYSE
Westfield Capital Management Company, L.P. has increased its beneficial ownership of IMAX Corp. common stock to 4.99%, acquiring 2,737,381 shares.
NYSE
GIC Private Limited has filed a Schedule 13G reporting a 5.23% beneficial ownership stake in IMAX Corporation.
NYSE
Westfield Capital Management Company, L.P. has reported a beneficial ownership of 5.01% in IMAX Corp, holding 2,704,872 shares as of April 30, 2026.
NYSE
Orbis Investment Management Limited and Allan Gray Australia Pty Ltd jointly reported a combined beneficial ownership of 9.6% of IMAX Corp's common stock.